CN104523917A - 一种治疗湿热内蕴型非酒精性脂肪肝的中药 - Google Patents
一种治疗湿热内蕴型非酒精性脂肪肝的中药 Download PDFInfo
- Publication number
- CN104523917A CN104523917A CN201410799929.5A CN201410799929A CN104523917A CN 104523917 A CN104523917 A CN 104523917A CN 201410799929 A CN201410799929 A CN 201410799929A CN 104523917 A CN104523917 A CN 104523917A
- Authority
- CN
- China
- Prior art keywords
- damp
- parts
- heat
- chinese medicine
- retention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 title claims abstract description 20
- 230000014759 maintenance of location Effects 0.000 title claims abstract description 17
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 241000345998 Calamus manan Species 0.000 claims description 11
- 235000012950 rattan cane Nutrition 0.000 claims description 11
- 235000019640 taste Nutrition 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 4
- 241000518307 Cassytha Species 0.000 abstract 1
- 240000001230 Hydrocotyle javanica Species 0.000 abstract 1
- 240000008436 Ipomoea aquatica Species 0.000 abstract 1
- 235000019004 Ipomoea aquatica Nutrition 0.000 abstract 1
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 240000005385 Jasminum sambac Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000208968 Securidaca Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 6
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010072268 Drug-induced liver injury Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 231100000594 drug induced liver disease Toxicity 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012317 liver biopsy Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗湿热内蕴型非酒精性脂肪肝的中药,该中药是由小鸦葱,风寒草,红马蹄草,五味藤,夏天无,白花蛇舌草,黄芩,栀子,蕹菜,无爷藤制成。临床可用于治疗湿热内蕴型非酒精性脂肪肝。
Description
技术领域
本发明属于中药技术领域,尤其是涉及一种治疗湿热内蕴型非酒精性脂肪肝的中药。
背景技术
非酒精性脂肪肝(NAFLD) 是以无过量饮酒史(酒精摄入量<20g/d) 以及肝细胞脂肪变性、气球样变、弥散性小叶轻度炎症和(或) 肝中央静脉、肝窦周围胶原沉积等为临床病理特点的慢性肝脏疾病,由于脂肪代谢紊乱导致肝实质细胞变性和脂肪贮积为特征的临床综合征。湿热内蕴型非酒精性脂肪肝最常见的症状表现为胁肋胀痛,脘腹痞闷,体倦乏力,大便秽浊,小便黄,口苦口干,舌红,苔黄厚或黄腻,脉弦滑。目前尚无治疗湿热内蕴型非酒精性脂肪肝的特效手段,一些化学药物的治疗效果及安全性问题尚需进一步检验。本发明制备得到的中药治疗湿热内蕴型非酒精性脂肪肝,取得了良好的效果。
发明内容
本发明的目的在于提供一种治疗效果好、有效率高、对人体无毒副作用的治疗湿热内蕴型非酒精性脂肪肝的中药。
本发明的目的是这样实现的,根据中医药理论,利用中药独特的药性,采用小鸦葱,风寒草,红马蹄草,五味藤,夏天无,白花蛇舌草,黄芩,栀子,蕹菜,无爷藤,按照一定的配伍要求,经过加工制成。
制备本发明中药由下述原料药制成:小鸦葱40-50份,风寒草 20-30份,红马蹄草20-30份,五味藤10-20份,夏天无10-20份,白花蛇舌草10-20份,黄芩10-20份,栀子10-20份,蕹菜8-15份,无爷藤6-12份。
本发明中药原料药的最佳重量份为:小鸦葱45份,风寒草 25份,红马蹄草25份,五味藤15份,夏天无15份,白花蛇舌草15份,黄芩15份,栀子15份,蕹菜12份,无爷藤8份。
本发明中药的药理作用如下:
小鸦葱:甘、苦、性寒。清热利湿,消痈,下乳。用于湿热泻痢,小便淋涩,痈肿疔毒,乳痈,乳汁不下等症。
风寒草:辛、微苦、性微温。祛风散寒,化痰止咳,解毒利湿,消积排石。临床用于风寒头痛,咳嗽痰多,咽喉肿痛,黄疸,胆道结石,尿路结石,痈疮疔毒,毒蛇咬伤等。
红马蹄草:苦、寒。清热利湿、化瘀止血、解毒。临床用于感冒,咳嗽,痰中带血,痢疾,泄泻,痛经,月经不调,跌打损伤,外伤出血,痈疮肿毒等症。
五味藤:辛、苦、凉。祛风除湿,散瘀止痛。用于皮炎,跌打损伤,风湿骨痛,急性肠胃炎等症。
夏天无:苦、辛、凉。归肝、肾经。祛风除湿,舒筋活血,通络止痛,降血压。用于风湿性关节炎,中风偏瘫,坐骨神经痛,小儿麻痹后遗症,腰肌劳损,高血压等。
白花蛇舌草:甘、寒。归心、肝、脾、大肠经。清热解毒,利湿。用于肺热喘咳,咽喉肿痛,肠痈,疖肿疮疡,毒蛇咬伤,热淋涩痛等。
黄芩:苦、寒,归肺、胃经。清热燥湿,泻火解毒。外用于痈肿疮毒、湿热痞闷。
栀子:苦、寒,归心、肝、肺、胃经。清热利湿,凉血解毒。用于热病烦闷、疮疡肿毒。
蕹菜:甘、寒。归肠、胃经。凉血止血,清热利湿。临床用于鼻衄,便秘,淋浊,便血,尿血,痔疮,痈肿,折伤,蛇虫咬伤等症。
无爷藤:微苦,甘、性凉。归肝、肺、肾、膀胱经。清热利湿,凉血解毒。临床用于感冒发热,热淋,石淋,湿热黄疸,泄泻,痢疾,咯血,衄血,风火赤眼,跌打损伤,外伤出血,疮疡溃烂,水火烫伤,疥疮癣癞等症。
非酒精性脂肪肝属多发和高发性疾病,饮食结构改变,高脂肪性食物摄入过多是主要原发因素。本病的危害,越来越引起医生和广大病患者的重视。控制原发病因,改善饮食结构,增加体育活动,增强体质已成为当务之急。对于已发病的患者,用中医药综合治疗,疗效是肯定的。辨证治疗本病,根据人体的阴阳寒热虚实情况,加减运用,多可治愈或缓解症状。本发明小鸦葱清热利湿,为君药,风寒草祛风散寒、化痰、利湿,红马蹄草清热利湿、解毒,为臣药,五味藤祛风散湿、散瘀止痛,夏天无祛风除湿、通络,白花蛇舌草清热解毒、利湿,黄芩清热燥湿、泻火解毒,栀子清热利湿、凉血解毒,蕹菜清热利湿,无爷藤清热利湿、凉血解毒,共奏清热利湿,燥湿化痰、祛风解毒之功,达到治疗湿热内蕴型非酒精性脂肪肝的目的。
本发明中药使用于2008年至2012年临床观察湿热内蕴型非酒精性脂肪肝症55例患者,临床报告如下:
1、一般资料
55例患者中,女性28例,男性27例,年龄最小31岁,最大55岁,平均年龄39.1岁。
2、诊断标准
参照《中医病证诊断疗效标准》:
①无饮酒史或饮酒折合乙醇量,男性每周<40g。②除外病毒性肝炎、药物性肝病、全胃肠性营养、肝豆状核变性等可导致脂肪肝的特定疾病。③除原发性疾病临床表现外,可伴乏力、消化不良、肝区隐痛、肝脾肿大等非特异性症状及体征。④可有体质量超重和(或)内脏性肥胖、空腹血糖增高、血脂紊乱、高血压等代谢综合征相关变化。⑤血清转氨酶和GGT水平可有轻至中轻度增高(<5倍正常值上限),通常以ALT增加为主。⑥肝脏影像学表现符合弥漫性脂肪肝影像学诊断要点。⑦肝活体组织检查组织学改变符合脂肪肝的病理学诊断要点。以上7项具备①~⑤项和第⑥或第⑦项中任一项可确定诊断。
湿热内蕴型非酒精性脂肪肝临床症状:胁肋胀痛,脘腹痞闷,体倦乏力,大便秽浊,小便黄,口苦口干,舌红,苔黄厚或黄腻,脉弦滑。
3、治疗方法
3.1处方:小鸦葱45g,风寒草 25g,红马蹄草25g,五味藤15g,夏天无15g,白花蛇舌草15g,黄芩15g,栀子15g,蕹菜12g,无爷藤8g。
3.2制备方法:上述药物按常规工艺制成汤剂。
3.3服用方法:每次1剂,每日2次,30天为1疗程。
3.4观察指标:记录患者症状、体征变化及饮食、体质量情况。治疗前后行B超检查肝、胆、胰、脾,抽取静脉血检测血清血脂、肝功能水平,包括总胆固醇(TC)、三酰甘油(TG)、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)。
4、治疗结果:
4.1参照《中医病证诊断疗效标准》:
临床治愈: 临床症状及体征消失,肝脏B超或CT检查、实验室检查恢复正常;
显效: 临床症状及体征明显改善,肝脏B超或CT检查,好转明显,实验室检查的各项指标下降40%以上;
未愈: 临床症状及体征改善不明显,肝脏B超或CT检查治疗前后无明显变化,实验室检查的各项指标无明显下降。
4.2结果:55例患者中,临床治愈29例(52.7%),显效21例(38.2%),未愈5例(9.1%),总有效率为90.9%。
5、典型病例
5.1孙某,男,42岁,肝功能示谷丙转氨酶(ALT)75U/L,谷草转氨酶(AST)41U/L,谷氨酰转肽酶(r-GGT):53U/L,血脂:胆固醇5.6mmol/l,甘油三脂5.9mmol/L。CT显示:重度脂肪肝。服用本发明药物,治疗1个疗程,诸症减轻,谷丙转氨酶(ALT)65U/L,谷草转氨酶(AST)35U/L,谷氨酰转肽酶(r-GGT):46U/L,血脂:胆固醇4.7mmol/l,甘油三脂5.0mmol/L继续服用3个疗程,复查肝功、血脂均正常,CT显示:肝胆脾胰未见明显异常,痊愈。半年后随访无复发。
5.2刘某,女,36岁,曾作肝功、血脂、彩超、CT等检查,确诊为湿热内蕴型非酒精性脂肪肝。血脂较高,转氨酶高。诊见舌紫暗,脉弦。服用本发明药物,每日1剂,1个疗程后,诸症减轻,继续服用1个疗程,复查肝功、血脂均正常,CT显示:肝胆脾胰未见明显异常,痊愈。半年后随访无复发。
具体实施方式
下面结合实施例对本发明作进一步的说明,下述该实施例仅用于说明本发明而对本发明没有限制。
实施例1,一种治疗湿热内蕴型非酒精性脂肪肝的中药,它是由下述原料药制成:小鸦葱40g,风寒草20g,红马蹄草20g,五味藤10g,夏天无10g,白花蛇舌草10g,黄芩10g,栀子10g,蕹菜8g,无爷藤6g。
实施例2,一种治疗湿热内蕴型非酒精性脂肪肝的中药,它是由下述原料药制成:小鸦葱45g,风寒草25g,红马蹄草25g,五味藤15g,夏天无15g,白花蛇舌草15g,黄芩15g,栀子15g,蕹菜12g,无爷藤8g。
实施例3,一种治疗湿热内蕴型非酒精性脂肪肝的中药,它是由下述原料药制成:小鸦葱50g,风寒草30g,红马蹄草30g,五味藤20g,夏天无20g,白花蛇舌草20g,黄芩20g,栀子20g,蕹菜15g,无爷藤12g。
Claims (2)
1.一种治疗湿热内蕴型非酒精性脂肪肝的中药,其特征在于包括以下原料药:
小鸦葱40-50份,风寒草 20-30份,红马蹄草20-30份,五味藤10-20份,夏天无10-20份,白花蛇舌草10-20份,黄芩10-20份,栀子10-20份,蕹菜8-15份,无爷藤6-12份。
2.根据权利要求1所述的中药,其特征在于包括以下原料药:
小鸦葱45份,风寒草 25份,红马蹄草25份,五味藤15份,夏天无15份,白花蛇舌草15份,黄芩15份,栀子15份,蕹菜12份,无爷藤8份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410799929.5A CN104523917A (zh) | 2014-12-22 | 2014-12-22 | 一种治疗湿热内蕴型非酒精性脂肪肝的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410799929.5A CN104523917A (zh) | 2014-12-22 | 2014-12-22 | 一种治疗湿热内蕴型非酒精性脂肪肝的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104523917A true CN104523917A (zh) | 2015-04-22 |
Family
ID=52839673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410799929.5A Pending CN104523917A (zh) | 2014-12-22 | 2014-12-22 | 一种治疗湿热内蕴型非酒精性脂肪肝的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104523917A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105147880A (zh) * | 2015-10-22 | 2015-12-16 | 曹显刚 | 一种治疗肝阴不足型非酒精性脂肪肝的中药 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413632A (zh) * | 2002-08-06 | 2003-04-30 | 漳州片仔癀药业股份有限公司 | 一种中药组合物的药物新用途 |
| KR20120022085A (ko) * | 2010-08-25 | 2012-03-12 | 주식회사 인섹트 바이오텍 | 콩잎 추출물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 제형 |
| CN103610797A (zh) * | 2013-12-20 | 2014-03-05 | 潘靖年 | 一种治疗湿热壅盛型角结膜炎的中药组合物 |
-
2014
- 2014-12-22 CN CN201410799929.5A patent/CN104523917A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413632A (zh) * | 2002-08-06 | 2003-04-30 | 漳州片仔癀药业股份有限公司 | 一种中药组合物的药物新用途 |
| KR20120022085A (ko) * | 2010-08-25 | 2012-03-12 | 주식회사 인섹트 바이오텍 | 콩잎 추출물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 제형 |
| CN103610797A (zh) * | 2013-12-20 | 2014-03-05 | 潘靖年 | 一种治疗湿热壅盛型角结膜炎的中药组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 中华中医药学会: "《中医内科常见病诊疗指南.西医疾病部分》", 31 July 2008, 中国中医药出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105147880A (zh) * | 2015-10-22 | 2015-12-16 | 曹显刚 | 一种治疗肝阴不足型非酒精性脂肪肝的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656535B (zh) | 一种治疗高脂血症的中药组合物及其制备方法 | |
| CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
| CN104013748A (zh) | 一种治疗湿热下注型肛窦炎的中药组合物 | |
| CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN102988813B (zh) | 一种治疗急性胆囊炎的中药制剂 | |
| CN103100003B (zh) | 一种治疗急性痛风性关节炎的中药组合物 | |
| CN104547313B (zh) | 一种治疗肺癌、乳腺癌、淋巴癌的药物及制备方法 | |
| CN102198261B (zh) | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 | |
| CN101703738B (zh) | 治疗胃炎、胃溃疡的中药 | |
| CN104523917A (zh) | 一种治疗湿热内蕴型非酒精性脂肪肝的中药 | |
| CN105169209A (zh) | 一种中药组合物 | |
| CN101129876A (zh) | 一种治疗酒渣鼻的中药组合物 | |
| CN104958672A (zh) | 一种治疗幽门螺旋杆菌感染性胃病的药物组合物及其制备方法 | |
| CN103386104B (zh) | 一种治疗丹毒的中药组合物及其制备方法 | |
| CN104324114A (zh) | 治疗痢疾的中药制剂 | |
| CN102641422B (zh) | 一种治疗急性荨麻疹的中成药 | |
| CN103432539A (zh) | 一种袪湿热湿毒的中药制剂 | |
| CN102626498B (zh) | 治疗慢性胰腺炎的前苓赤金汤 | |
| CN101085266A (zh) | 治疗尿毒症的一种中药制剂 | |
| CN103861077B (zh) | 一种有效治疗急性胰腺炎的制剂 | |
| CN104491427A (zh) | 一种治疗脾虚肝郁型非酒精性脂肪肝的中药 | |
| CN105343666A (zh) | 一种治疗肝脾不和型溃疡性结肠炎的中药 | |
| CN105434662A (zh) | 一种治疗阿弗他口炎的中药制剂 | |
| CN104547223A (zh) | 一种治疗痰瘀互结型非酒精性脂肪肝的中药 | |
| CN103191277B (zh) | 一种治疗气滞证型胆结石的中药汤剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150422 |
|
| RJ01 | Rejection of invention patent application after publication |